Bridget Martell
Board Member
Delcath Systems, Inc. (DCTH)Board Member
Aligos Therapeutics, Inc. (ALGS)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Bridget Martell
Bridget Martell is recorded as Board Member at Delcath Systems, Inc. (DCTH) and Board Member at Aligos Therapeutics, Inc. (ALGS). Bridget Martell was last confirmed as Board Member at Achieve Life Sciences, Inc. (ACHV) in a filing dated April 28, 2025. Delcath Systems, Inc. reported in an 8-K filed May 29, 2024 that Bridget Martell was appointed Class III Director, effective May 23, 2024. The proxy statement of Kura Oncology, Inc. reports total compensation of $2,431,646 for Bridget Martell in fiscal 2020, including a base salary of $397,708.
“in connection with Roger Stoll's retirement from the Company's Board, on May 23, 2024, the Company appointed Bridget Martell, M.A. M.D., as a Class III Director on the Company's Board, commencing on May 23, 2024 and continuing until her term on the Board expires at the Company's 2027 Annual Meeting.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-01-01–present
-
Current
2021-01-01–present
-
2021-01-01–2025-04-28
Last confirmed by a filing; no departure on record
-
Kura Oncology, Inc. (KURA)
Proxy statement
Start not stated–2021-04-29
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Aligos Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Lawrence M. Blatt CEO, Board Member
- Lesley Ann Calhoun CFO, COO
- Lucinda Y. Quan General Counsel
- Nikhil Aneja Chief Accounting Officer
- Bridget Martell, M.A., M.D. Board Member
- Bridget Martell, M.D. Board Member
- Carole Nuechterlein Board Member
- Carole Nuechterlein, J.D. Board Member
- Heather Preston Board Member
- Heather Preston, M.D. Board Member
Leadership on record at Delcath Systems, Inc.
Other people whose current roles at this company are on record from its filings.
- Gerard Michel CEO, Board Member
- John Purpura CEO
- Sandra Pennell CFO
- Martha Rook COO
- Martha S. Rook COO
- David Hoffman General Counsel
- Christine Padula Chief Accounting Officer
- Bridget Martell, M.A. M.D. Board Member
- Elizabeth Czerepak Board Member
- Gilad Aharon Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Kura Oncology, Inc. (KURA) | M.A., M.D.^(^^14)^ Former Acting Chief Medical Officer | $397,708 | $2,431,646 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.